Login Register
About Us
Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Advanced Search
Back
4Engineers
· Chemical Engineering Online
AI summary

Novonesis Group has signed an agreement with TurtleTree—an expert in precision-fermented ingredients and the first to receive a US GRAS “No Objection Letter” for its fermented lactoferrin LF+—to advance commercialization of fermented lactoferrin. Novonesis is also making a minor investment in TurtleTree, joined by 321Catalyst Ventures, the corporate venture arm of Mitsui Chemicals.

Which applications do you think will benefit first from precision‑fermented lactoferrin—infant nutrition, sports and wellness, or broader functional foods—and why?

Commercialization of fermented lactoferrin takes a major step forward

This article was originally posted on Chemical Engineering.
View article ->

Novonesis Group (Lyngby, Denmark) announced an agreement with TurtleTree, an expert in precision fermented ingredients, and the first company to receive a US GRAS “No Objection Letter” for its precision fermented lactoferrin LF+®. Simultaneously, Novonesis is making a minor investment into TurtleTree.  321Catalyst Ventures, the CVC-arm of Mitsui Chemicals, Inc. (HQ: Tokyo) joins the investment. […]

The post Commercialization of fermented lactoferrin takes a major step forward appeared first on Chemical Engineering.

Login to comment

Login

Related Conversations

Recent Conversations

Your Conversations

Report content
Reason Description